source
- Viridian data lift prospects for thyroid eye disease drugWhereas earlier Phase 3 results disappointed Wall Street, new findings in people with “chronic” disease were viewed by analysts as much more competitive with Amgen’s Tepezza.BioPharma Dive · 3mo ago↗ source
- The Type of Fat—Not the Amount—Fuels Pancreatic CancerResearch from Yale Cancer Center showed that the type of fat consumed may matter more than amount in pancreatic cancer.onclive · 3mo ago↗ source
- Iopofosine I 131 Follow-Up Data Show Strong Efficacy in Waldenström MacroglobulinemiaIopofosine I 131 produced strong responses in Waldenström macroglobulinemia, according to 12-month folllow-up data from CLOVER WaM requested by the FDA.onclive · 3mo ago↗ source